Administration of recombinant MANF into mouse brain has been shown to downregulate inflammation by decreasing NF-κB-mediated pro-inflammatory cytokine production in vivo in an ischemic stroke model in aged mice [23] and in vitro after oxygen–glucose deprivation [23, 83]. This evidence concerns the gene MANF and ischemic stroke.